Taking the opportunity of global borders reopening, leaders of our laboratory units across the world gathered in Singapore for the inaugural IHH Laboratories Strategic Retreat that was held over 2 days on 18 & 19 July.
The retreat led by Ashok Pandit, Group Chief Strategy & Business Development Officer, was filled with dynamic discussions, alignment of strategies and synergy amongst 50 over attendees from our global labs, Legal, Finance, HR and Corporate Communications business units.
‘Developing the laboratory business’, as shared by Dr Kelvin Loh, Managing Director & CEO, earlier this year, is one of our new growth peaks and core business of IHH Healthcare.
“Post-Covid megatrends certainly favour the laboratory business; there is huge growth potential as the healthcare consumer goes beyond illness to wellness testing.”- Dr Kelvin Loh
With this growth opportunity in mind, our leaders of major laboratory units such as Pantai Premier Pathology in Malaysia, Parkway Laboratories in Singapore, Acibadem's LabMed in Turkey and Fortis’ SRL Diagnostics in India, held fervent conversations & consultations with one another on how we can develop better healthcare solutions for our consumers with topics ranging from ‘Investing in the Future’ to the ‘Importance of Data & Digitalisation’.
It is heartening to know that beyond the discussions of developing our laboratory business, the core of wanting to do better and emerging stronger, comes with the commitment of our purpose in touching lives and transforming care for our patients.
Here’s to the next laboratory retreat!
Related Stories
Friends of Fortis Programme Highlights Robotic Knee Replacement Outcomes in Amritsar
Project Renaissance at Mount Elizabeth Hospital, Where Legacy Meets the Future of Care
Over a span of 1,095 days, Project Renaissance marked a significant chapter in the evolution of Mount Elizabeth Hospital, one of Singapore’s most established private healthcare institutions. Conceived as a strategic transformation rather than a conventional refurbishment, the initiative sought to position the hospital for the demands of a rapidly changing healthcare landscape.
IHH Healthcare North Asia Strengthens Integrated Care Through Strategic Partnership
2026 IHH Global Town Hall: Building a Future-ready Workforce
'Building a Future-ready Workforce' took centre stage at IHH Healthcare's 2026 Global Town Hall on 9 February, bringing colleagues together across 10 countries in a truly hybrid experience that underscored the group's commitment to future-proof healthcare.
IHH Malaysia Partners Libyan Government for Medical Referrals
IHH Healthcare Malaysia signed a Memorandum of Understanding (MOU) with The Government of Libya on 9 February, establishing a structured medical referral pathway for Libyan civil servants requiring specialist treatment at 18 hospitals across IHH’s Malaysian network.
Agilus Diagnostics Expands Access to Next-Generation Precision Genomics
Agilus Diagnostics, a subsidiary of Fortis Healthcare, has installed the Illumina NovaSeq X sequencing platform at its Mumbai reference laboratory, marking a major step forward for precision genomics in India.
